Water vapor treatment for grade group 3 prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial uses water vapor (steam) to destroy a small, localized prostate cancer. The goal is to treat the cancer while possibly reducing side effects compared to removing the whole prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Grade Group 3 prostate cancer (a specific stage pattern found on biopsy).
- Your PSA level is 20 ng/mL or lower.
- Your prostate is between 20 and 80 cubic centimeters (about the size of a walnut to a small egg).
- You are at least 50 years old and expected to live at least 10 more years.
- Your cancer has not spread outside the prostate, based on a special scan (PSMA PET) and MRI.
- You had a prostate MRI and a targeted biopsy within the last 6 months that confirm the cancer is only in one area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks the long-term effects of Vanquish, a water vapor therapy for prostate cancer. It's for people who are already getting or have gotten this treatment to see how well it works over time.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
This trial tests a laser treatment to destroy cancer cells in the prostate for people with early-stage prostate cancer who choose not to have surgery. It aims to target only the cancer while sparing healthy tissue.
This trial tests a newer, more precise type of radiation therapy for intermediate-risk prostate cancer using micro-ultrasound guidance to target the tumor. It aims to shorten treatment and reduce side effects while maintaining effectiveness.
This study tests a new, less invasive treatment using targeted microwave ablation (TMA) to destroy prostate cancer tumors. It is designed for men with early-stage, low to intermediate-risk prostate cancer that hasn't spread, offering a possible alternative to surgery or radiation.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.